Less than one year ago, Tammy Fairley’s world was jolted by the words every cancer patient fears.
“The doctor called me and basically said, ‘Sorry, there’s nothing I can do for you,’” Fairley said. “‘It’s time for you to get your affairs in order and you should seek hospice care.’ That was shocking.”
Diagnosed with Stage 3 ovarian cancer in February 2015, Fairley underwent chemotherapy where she was living in Charlotte, North Carolina. The effects of the treatment left her unable to work, so the 51-year-old native of Shelby, Nebraska, moved back to her home state where she continued treatment in Lincoln and Omaha.
Last July, Fairley wasn’t feeling well and, shortly after undergoing a CT scan, received the discouraging outlook.
After a few days of contemplation and tears, Fairley spoke to a different physician in Omaha who helped her search for a clinical trial. Eventually, Fairley was given the name of David Crockett, MD, a medical oncologist at the CHI Health St. Francis Cancer Treatment Center in Grand Island.
With Crockett’s help, Fairley entered a clinical trial and started receiving infusion treatment at the end of August. Fairley’s most recent scan revealed that four of the six tumors were gone and two others shrunk significantly.